3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hepatitis B
4
Lymphoma
3
Carcinoma, Hepatocellular
3
Recurrence
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Radiofrequency Ablation
4
gadolinium ethoxybenzyl DTPA
2
atezolizumab
2
Sorafenib
2
Oxaliplatin
2
Fluorouracil
2
Dexmedetomidine
2
Bevacizumab
2
voxilaprevir
1
velpatasvir
1
huachansu
1
entecavir
1
Tobacco Use Cessation Devices
1
Tinzaparin
1
Telbivudine
1
Technetium Tc 99m Aggregated Albumin
1
Sofosbuvir
1
Sevoflurane
1
Ribavirin
1
Radionuclide Generators
1
Psychiatric Rehabilitation
1
Propofol
1
Pregabalin
1
Polymerase Chain Reaction
1
Nivolumab
1
Neuroleptanalgesia
1
Lamivudine
1
Immunotherapy
1
Gene Expression Profiling
1
Galactose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Liver Neoplasms
×
entecavir
×
Clear all
NCT00555334
2009-04-01
LAM-RFA
Sun Yat-sen University
Phase 4
Unknown
200 enrolled